IRD Return on Tangible Equity | Opus Genetics, Inc.

Opus Genetics, Inc. (IRD) Return on Tangible Equity

2026-06-30: Return Tang Equity 828.66%.
2026-03-31: Return Tang Equity 233.29%.
2025-12-31: Return Tang Equity -323.11%.
2025-09-30: Return Tang Equity -1143.00%.

Complete source-backed return tang equity history.

Available history: 2002-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	828.66%
2026-03-31	233.29%
2025-12-31	-323.11%
2025-09-30	-1143.00%
2025-06-30	-333.51%
2025-03-31	-1155.53%
2024-12-31	-855.62%
2024-09-30	-79.28%
2024-06-30	-34.71%
2024-03-31	-24.54%
2023-12-31	-20.01%
2023-09-30	57.18%
2023-06-30	49.49%
2023-03-31	45.31%
2022-12-31	38.69%
2022-09-30	-188.31%
2022-06-30	-151.18%
2022-03-31	-140.54%
2021-12-31	-255.12%
2021-09-30	-335.80%
2021-06-30	-292.99%
2021-03-31	-616.81%
2020-12-31	182.82%
2020-09-30	56.77%
2020-06-30	68.96%
2020-03-31	81.72%
2019-12-31	81.60%
2019-09-30	-84.07%
2019-06-30	-97.35%
2019-03-31	-91.82%
2018-12-31	845.71%
2018-09-30	-231.51%
2018-06-30	-92.30%
2018-03-31	-38.47%
2017-12-31	-150.84%
2017-09-30	-147.00%
2017-06-30	-151.29%
2017-03-31	-2369.95%
2016-12-31	-54.56%
2016-09-30	-67.48%
2016-06-30	-80.90%
2016-03-31	-82.87%
2015-12-31	-76.61%
2015-09-30	-77.61%
2015-06-30	-54.23%
2015-03-31	-35.05%
2014-12-31	-69.68%
2014-09-30	-66.55%
2014-06-30	-63.57%
2014-03-31	-80.51%
2013-12-31	-75.24%
2013-09-30	-69.38%
2013-06-30	-139.64%
2013-03-31	-67.06%
2012-12-31	-65.31%
2012-09-30	-122.05%
2012-06-30	-55.60%
2012-03-31	-104.52%
2011-12-31	-105.97%
2011-09-30	-141.02%
2011-06-30	-110.26%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-323.11%
2024-12-31	-855.62%
2023-12-31	-20.01%
2022-12-31	38.69%
2021-12-31	-255.12%
2020-12-31	182.82%
2019-12-31	81.60%
2018-12-31	845.71%
2017-12-31	-150.84%
2016-12-31	-54.56%
2015-12-31	-76.61%
2014-12-31	-69.68%
2013-12-31	-75.24%
2012-12-31	-65.31%
2011-12-31	-105.97%
2010-12-31	-134.89%
2009-12-31	-59.22%
2008-12-31	141.46%
2007-12-31	-463.62%
2006-12-31	-201.81%
2005-12-31	-131.47%
2004-12-31	580.22%
2003-12-31	-112.05%
2002-12-31	-43.53%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
RELMADA THERAPEUTICS, INC. (RLMD)	United States	$0.406B	-11.92
Arcturus Therapeutics Holdings Inc. (ARCT)		$0.402B	-2.05
GALECTIN THERAPEUTICS INC (GALT)	United States	$0.399B	-11.06
ARS Pharmaceuticals, Inc. (SPRY)	United States	$0.414B	-3.70
Atea Pharmaceuticals, Inc. (AVIR)	United States	$0.414B	-2.26
Turn Therapeutics Inc. (TTRX)	United States	$0.397B	-25.68
DiaMedica Therapeutics Inc. (DMAC)	United States	$0.423B	-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)	Ireland	$0.428B	-11.53
Rezolute, Inc. (RZLT)	United States	$0.382B	-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)	United States	$0.438B	-75.63